Ilan Ganot Biography and Net Worth

Co-Founder and Strategic Advisor to the CEO of Solid Biosciences

Ilan Ganot is one of Solid’s founders and has served as a member of Solid’s Board of Directors since the Company’s inception in 2013. He also served as Solid’s Chief Executive Officer from 2013 to December 2022 and as Solid’s President from June 2018 to December 2022.

Ilan Ganot is currently the Chief Executive Officer and a member of the Board of Alesta Therapeutics, a biotechnology company focused on the development of innovative small molecule therapies for rare diseases.

Prior to starting Solid, Mr. Ganot spent a decade as an investment banker on Wall Street working for JPMorgan, Nomura Securities and Lehman Brothers in London, Hong Kong and New York.

Mr. Ganot is also a member of the Board of Directors of Minovia Therapeutics, a biotechnology company.

Mr. Ganot received his M.B.A. from London Business School and holds law and business degrees from the Interdisciplinary Center in Herzliya, Israel. Mr. Ganot also practiced corporate law in Israel and was a Captain in the Israeli Defense Forces.

What is Ilan Ganot's net worth?: The estimated net worth of Ilan Ganot is at least $69.20 thousand as of January 28th, 2025. Mr. Ganot owns 11,689 shares of Solid Biosciences stock worth more than $69,199 as of December 4th. This net worth estimate does not reflect any other assets that Mr. Ganot may own. Additionally, Mr. Ganot receives a salary of $847,870.00 as Co-Founder and Strategic Advisor to the CEO at Solid Biosciences. Learn More about Ilan Ganot's net worth.
How old is Ilan Ganot?: Mr. Ganot is currently 50 years old. There are 7 older executives and no younger executives at Solid Biosciences. The oldest executive at Solid Biosciences is Mr. Ian F. Smith A.C.A., C.P.A., Executive Chair, who is 58 years old. Learn More on Ilan Ganot's age.
What is Ilan Ganot's salary?: As the Co-Founder and Strategic Advisor to the CEO of Solid Biosciences Inc., Mr. Ganot earns $847,870.00 per year. The highest earning executive at Solid Biosciences is Mr. Alexander G. Cumbo, President, CEO & Director, who commands a salary of $918,550.00 per year. Learn More on Ilan Ganot's salary.
How do I contact Ilan Ganot?: The corporate mailing address for Mr. Ganot and other Solid Biosciences executives is 141 PORTLAND STREET FIFTH FLOOR, CAMBRIDGE MA, 02139. Solid Biosciences can also be reached via phone at (617) 337-4680 and via email at [email protected]. Learn More on Ilan Ganot's contact information.
Has Ilan Ganot been buying or selling shares of Solid Biosciences?: Ilan Ganot has not been actively trading shares of Solid Biosciences during the last quarter. Most recently, Ilan Ganot sold 144 shares of the business's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $3.11, for a transaction totalling $447.84. Following the completion of the sale, the director now directly owns 11,689 shares of the company's stock, valued at $36,352.79. Learn More on Ilan Ganot's trading history.
Who are Solid Biosciences' active insiders?: Solid Biosciences' insider roster includes Gabriel Brooks (Chief Medical Officer), Alexander Cumbo (President & CEO), Ilan Ganot (Co-Founder and Strategic Advisor to the CEO), Jessie Hanrahan (Chief Regulatory & Preclinical Operations Officer), Paul Herzich (CTO), David Howton (COO), Clare Kahn (Director), Carl Morris (Insider), and Kevin Tan (CFO). Learn More on Solid Biosciences' active insiders.
Are insiders buying or selling shares of Solid Biosciences?: During the last twelve months, Solid Biosciences insiders bought shares 1 times. They purchased a total of 1,860 shares worth more than $9,932.40. During the last twelve months, insiders at the sold shares 8 times. They sold a total of 31,092 shares worth more than $155,239.01. The most recent insider tranaction occured on December, 3rd when COO David T Howton sold 4,932 shares worth more than $25,202.52. Insiders at Solid Biosciences own 1.9% of the company. Learn More about insider trades at Solid Biosciences.
Information on this page was last updated on 12/3/2025.

Ilan Ganot Insider Trading History at Solid Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/28/2025	Sell	144	$3.11	$447.84	11,689
1/6/2025	Sell	1,056	$4.31	$4,551.36	11,445
5/2/2024	Sell	462	$10.33	$4,772.46	9,507
1/29/2024	Sell	139	$7.99	$1,110.61	8,416
1/3/2024	Sell	1,142	$5.30	$6,052.60	8,167
5/2/2023	Sell	487	$4.85	$2,361.95	4,153
1/27/2023	Sell	1,382	$7.49	$10,351.18	84,591
2/10/2022	Sell	463	$1.12	$518.56
1/28/2021	Sell	10,713	$6.14	$65,777.82
7/28/2020	Sell	11,124	$2.42	$26,920.08
11/15/2018	Sell	50,000	$30.84	$1,542,000.00

Ilan Ganot Buying and Selling Activity at Solid Biosciences

Solid Biosciences Company Overview

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich's ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Today's Range

Now: $5.92

$5.36

$5.97

50 Day Range

MA: $5.34

$3.93

$6.40

2 Week Range

Now: $5.92

$2.41

$7.37

Volume

1,597,066 shs

Average Volume

1,045,629 shs

Market Capitalization

$461.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.97

Ilan Ganot Biography and Net Worth

What is Ilan Ganot's net worth?

How old is Ilan Ganot?

What is Ilan Ganot's salary?

How do I contact Ilan Ganot?

Has Ilan Ganot been buying or selling shares of Solid Biosciences?

Who are Solid Biosciences' active insiders?

Are insiders buying or selling shares of Solid Biosciences?